Journal of Antimicrobial Chemotherapy (2001) 48, 59-64
© 2001 The British Society for Antimicrobial Chemotherapy
Supplement |
Detection of ß-lactamase-mediated resistance
a Antibiotic Resistance Monitoring and Reference Laboratory, Central Public Health Laboratory, 61 Colindale Avenue, London NW9 5HT; b Clinical Microbiology and Public Health Laboratory, Addenbrooke's Hospital, Hills Road, Cambridge CB2 2QW, UK
Abstract
ß-Lactams are the most widely used antibiotics, and ß-lactamases are the greatest source of resistance to them. An understanding of ß-lactamase detection and identification is therefore valuable. Colorimetric, acidimetric and iodometric tests of ß-lactamase production are good, rapid indicators of penicillin and ampicillin resistance in Haemophilus, Moraxella and Neisseria spp. These methods can also be applied to Gram-negative aerobic bacilli but are less useful, since the usual question is not whether a ß-lactamase is produced by these organisms, but which ß-lactamase? Accurate identification of the ß-lactamases of Enterobacteriaceae demands gene or protein sequencing, but the broad type of enzyme produced by an isolate can often be inferred from antibiotic susceptibility data. Resistance to ceftazidime or cefpodoxime implies extended-spectrum ß-lactamase (ESBL) production in Escherichia coli and Klebsiella spp., especially if susceptibility to cefoxitin is retained. ESBL production can be confirmed with double disc tests or with various commercial kits. Derepression of AmpC ß-lactamases in Enterobacter spp. and Citrobacter freundii is another important mechanism and can be inferred from cross-resistance to ß-lactamase inhibitor combinations and to all cephalosporins except fourth-generation agents. Antagonism between cefoxitin and cefotaxime can be used to infer the presence of inducible AmpC enzymes in these species, indicating the risk of segregation of derepressed mutants, but in general this risk is better predicted from accurate speciation.
Notes
* Corresponding author. Tel: +44-20-8200-4400; Fax: +44-20-8200-3292; E-mail: dlivermore{at}phls.nhs.uk
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J.-L. A. N. Murk, E. R. Heddema, D. L. J. Hess, J. A. Bogaards, C. M. J. E. Vandenbroucke-Grauls, and Y. J. Debets-Ossenkopp Enrichment Broth Improved Detection of Extended-Spectrum-Beta-Lactamase-Producing Bacteria in Throat and Rectal Surveillance Cultures of Samples from Patients in Intensive Care Units J. Clin. Microbiol., June 1, 2009; 47(6): 1885 - 1887. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Ll. Jones, R. E. Warren, S. J. Skidmore, V. A. Davies, T. Gibreel, and M. Upton Prevalence and distribution of plasmid-mediated quinolone resistance genes in clinical isolates of Escherichia coli lacking extended-spectrum {beta}-lactamases J. Antimicrob. Chemother., December 1, 2008; 62(6): 1245 - 1251. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Pillar, M. K. Torres, N. P. Brown, D. Shah, and D. F. Sahm In Vitro Activity of Doripenem, a Carbapenem for the Treatment of Challenging Infections Caused by Gram-Negative Bacteria, against Recent Clinical Isolates from the United States Antimicrob. Agents Chemother., December 1, 2008; 52(12): 4388 - 4399. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Qin, D. M. Zerr, S. J. Weissman, J. A. Englund, D. M. Denno, E. J. Klein, P. I. Tarr, J. Kwong, J. R. Stapp, L. G. Tulloch, et al. Prevalence and Mechanisms of Broad-Spectrum {beta}-Lactam Resistance in Enterobacteriaceae: a Children's Hospital Experience Antimicrob. Agents Chemother., November 1, 2008; 52(11): 3909 - 3914. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Livermore, R. Hope, G. Brick, M. Lillie, R. Reynolds, and on behalf of the BSAC Working Parties on Resistanc Non-susceptibility trends among Enterobacteriaceae from bacteraemias in the UK and Ireland, 2001-06 J. Antimicrob. Chemother., November 1, 2008; 62(suppl_2): ii41 - ii54. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Pillar, M. K. Aranza, D. Shah, and D. F. Sahm In vitro activity profile of ceftobiprole, an anti-MRSA cephalosporin, against recent Gram-positive and Gram-negative isolates of European origin J. Antimicrob. Chemother., March 1, 2008; 61(3): 595 - 602. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Beceiro, F. Fernandez-Cuenca, A. Ribera, L. Martinez-Martinez, A. Pascual, J. Vila, J. Rodriguez-Bano, J. M. Cisneros, J. Pachon, G. Bou, et al. False extended-spectrum {beta}-lactamase detection in Acinetobacter spp. due to intrinsic susceptibility to clavulanic acid J. Antimicrob. Chemother., February 1, 2008; 61(2): 301 - 308. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Jain, J. Andrews, A. Fraise, and N. Brenwald Rapid detection of extended-spectrum {beta}-lactamase-producing Gram-negative bacilli in blood cultures J. Antimicrob. Chemother., September 1, 2007; 60(3): 652 - 654. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Tristram, M. R. Jacobs, and P. C. Appelbaum Antimicrobial Resistance in Haemophilus influenzae Clin. Microbiol. Rev., April 1, 2007; 20(2): 368 - 389. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Wiegand, H. K. Geiss, D. Mack, E. Sturenburg, and H. Seifert Detection of Extended-Spectrum Beta-Lactamases among Enterobacteriaceae by Use of Semiautomated Microbiology Systems and Manual Detection Procedures J. Clin. Microbiol., April 1, 2007; 45(4): 1167 - 1174. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Al Naiemi, E. R. Heddema, A. Bart, E. de Jonge, C. M. Vandenbroucke-Grauls, P. H. M. Savelkoul, and B. Duim Emergence of multidrug-resistant Gram-negative bacteria during selective decontamination of the digestive tract on an intensive care unit J. Antimicrob. Chemother., October 1, 2006; 58(4): 853 - 856. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. A. C. Potz, R. Hope, M. Warner, A. P. Johnson, D. M. Livermore, and on behalf of the London & South East ESBL Project Prevalence and mechanisms of cephalosporin resistance in Enterobacteriaceae in London and South-East England J. Antimicrob. Chemother., August 1, 2006; 58(2): 320 - 326. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Juan, B. Moya, J. L. Perez, and A. Oliver Stepwise Upregulation of the Pseudomonas aeruginosa Chromosomal Cephalosporinase Conferring High-Level {beta}-Lactam Resistance Involves Three AmpD Homologues. Antimicrob. Agents Chemother., May 1, 2006; 50(5): 1780 - 1787. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Rankin, J. M. Whichard, K. Joyce, L. Stephens, K. O'Shea, H. Aceto, D. S. Munro, and C. E. Benson Detection of a blaSHV Extended-Spectrum {beta}-Lactamase in Salmonella enterica Serovar Newport MDR-AmpC J. Clin. Microbiol., November 1, 2005; 43(11): 5792 - 5793. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. A. Naiemi, B. Duim, P. H. M. Savelkoul, L. Spanjaard, E. de Jonge, A. Bart, C. M. Vandenbroucke-Grauls, and M. D. de Jong Widespread Transfer of Resistance Genes between Bacterial Species in an Intensive Care Unit: Implications for Hospital Epidemiology J. Clin. Microbiol., September 1, 2005; 43(9): 4862 - 4864. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Yagi, J.-i. Wachino, H. Kurokawa, S. Suzuki, K. Yamane, Y. Doi, N. Shibata, H. Kato, K. Shibayama, and Y. Arakawa Practical Methods Using Boronic Acid Compounds for Identification of Class C {beta}-Lactamase-Producing Klebsiella pneumoniae and Escherichia coli J. Clin. Microbiol., June 1, 2005; 43(6): 2551 - 2558. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Jonathan Screening for Extended-Spectrum Beta-Lactamase-Producing Pathogenic Enterobacteria in District General Hospitals J. Clin. Microbiol., March 1, 2005; 43(3): 1488 - 1490. [Full Text] [PDF]
|
|
|
|
|
|
E. Sturenburg, M. Lang, M. A. Horstkotte, R. Laufs, and D. Mack Evaluation of the MicroScan ESBL plus confirmation panel for detection of extended-spectrum {beta}-lactamases in clinical isolates of oxyimino-cephalosporin-resistant Gram-negative bacteria J. Antimicrob. Chemother., November 1, 2004; 54(5): 870 - 875. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Pai, C.-I. Kang, J.-H. Byeon, K.-D. Lee, W. B. Park, H.-B. Kim, E.-C. Kim, M.-d. Oh, and K.-W. Choe Epidemiology and Clinical Features of Bloodstream Infections Caused by AmpC-Type-{beta}-Lactamase-Producing Klebsiella pneumoniae Antimicrob. Agents Chemother., October 1, 2004; 48(10): 3720 - 3728. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Woodford, M. E. Ward, M. E. Kaufmann, J. Turton, E. J. Fagan, D. James, A. P. Johnson, R. Pike, M. Warner, T. Cheasty, et al. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum {beta}-lactamases in the UK J. Antimicrob. Chemother., October 1, 2004; 54(4): 735 - 743. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Nagano, Y. Nagano, C. Cordevant, N. Shibata, and Y. Arakawa Nosocomial Transmission of CTX-M-2 {beta}-Lactamase-Producing Acinetobacter baumannii in a Neurosurgery Ward J. Clin. Microbiol., September 1, 2004; 42(9): 3978 - 3984. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Grimm, S. Ezaki, M. Susa, C. Knabbe, Rolf. D. Schmid, and T. T. Bachmann Use of DNA Microarrays for Rapid Genotyping of TEM Beta-Lactamases That Confer Resistance J. Clin. Microbiol., August 1, 2004; 42(8): 3766 - 3774. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Doi, J.-i. Wachino, M. Ishiguro, H. Kurokawa, K. Yamane, N. Shibata, K. Shibayama, K. Yokoyama, H. Kato, T. Yagi, et al. Inhibitor-Sensitive AmpC {beta}-Lactamase Variant Produced by an Escherichia coli Clinical Isolate Resistant to Oxyiminocephalosporins and Cephamycins Antimicrob. Agents Chemother., July 1, 2004; 48(7): 2652 - 2658. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Sturenburg, I. Sobottka, D. Noor, R. Laufs, and D. Mack Evaluation of a new cefepime-clavulanate ESBL Etest to detect extended-spectrum {beta}-lactamases in an Enterobacteriaceae strain collection J. Antimicrob. Chemother., July 1, 2004; 54(1): 134 - 138. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Reynolds, N. Potz, M. Colman, A. Williams, D. Livermore, A. MacGowan, and on behalf of the BSAC Extended Working Party on Ba Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001-2002: the BSAC Bacteraemia Resistance Surveillance Programme J. Antimicrob. Chemother., June 1, 2004; 53(6): 1018 - 1032. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. A. C. Potz, M. Colman, M. Warner, R. Reynolds, and D. M. Livermore False-positive extended-spectrum {beta}-lactamase tests for Klebsiella oxytoca strains hyperproducing K1 {beta}-lactamase J. Antimicrob. Chemother., March 1, 2004; 53(3): 545 - 547. [Full Text] [PDF]
|
|
|
|
|
|
J. Heritage, P. A. Chambers, C. Tyndall, and E. S. Buescher SHV-34: an extended-spectrum {beta}-lactamase encoded by an epidemic plasmid J. Antimicrob. Chemother., December 1, 2003; 52(6): 1015 - 1017. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. De Gheldre, V. Avesani, C. Berhin, M. Delmee, and Y. Glupczynski Evaluation of Oxoid combination discs for detection of extended-spectrum {beta}-lactamases J. Antimicrob. Chemother., October 1, 2003; 52(4): 591 - 597. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. E. Aibinu, V. C. Ohaegbulam, E. A. Adenipekun, F. T. Ogunsola, T. O. Odugbemi, and B. J. Mee Extended-Spectrum {beta}-Lactamase Enzymes in Clinical Isolates of Enterobacter Species from Lagos, Nigeria J. Clin. Microbiol., May 1, 2003; 41(5): 2197 - 2200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Crowley and G. Ratcliffe Extended-spectrum {beta}-lactamases in Enterobacter cloacae: underestimated but clinically significant! J. Antimicrob. Chemother., May 1, 2003; 51(5): 1316 - 1317. [Full Text] [PDF]
|
|
|
|
|
|
M. Sanguinetti, B. Posteraro, T. Spanu, D. Ciccaglione, L. Romano, B. Fiori, G. Nicoletti, S. Zanetti, and G. Fadda Characterization of Clinical Isolates of Enterobacteriaceae from Italy by the BD Phoenix Extended-Spectrum {beta}-Lactamase Detection Method J. Clin. Microbiol., April 1, 2003; 41(4): 1463 - 1468. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. S. Babini, M. Yuan, L. M. C. Hall, and D. M. Livermore Variable susceptibility to piperacillin/tazobactam amongst Klebsiella spp. with extended-spectrum {beta}-lactamases J. Antimicrob. Chemother., March 1, 2003; 51(3): 605 - 612. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. P. Brenwald, G. Jevons, J. M. Andrews, J.-H. Xiong, P. M. Hawkey, and R. Wise An outbreak of a CTX-M-type {beta}-lactamase-producing Klebsiella pneumoniae: the importance of using cefpodoxime to detect extended-spectrum {beta}-lactamases J. Antimicrob. Chemother., January 1, 2003; 51(1): 195 - 196. [Full Text] [PDF]
|
|
|
|
|
|
C. Pepperell, J. V. Kus, M. A. Gardam, A. Humar, and L. L. Burrows Low-Virulence Citrobacter Species Encode Resistance to Multiple Antimicrobials Antimicrob. Agents Chemother., November 1, 2002; 46(11): 3555 - 3560. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-J. Yan, W.-C. Ko, Y.-C. Jung, C.-L. Chuang, and J.-J. Wu Emergence of Klebsiella pneumoniae Isolates Producing Inducible DHA-1 {beta}-Lactamase in a University Hospital in Taiwan J. Clin. Microbiol., September 1, 2002; 40(9): 3121 - 3126. [Abstract] [Full Text] [PDF]
|
|